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Non-Technical Summary 
Reactive oxygen-based molecules generated within muscle fibres in both exercise and pathological 
conditions can greatly affect muscle function.  These and consequent reactions can lead to either 
decreased or increased force response by the contractile proteins, but the mechanisms are unknown.  
This study demonstrates that the increase in force response appears to be due to a specific chemical 
process, known as S-glutathionylation, of a particular cysteine residue present on the troponin I 
molecule in fast-twitch muscle fibres, which is involved in sensing and responding to changes in 
intracellular calcium levels.  S-glutathionylation can occur when glutathione, the primary cellular 
anti-oxidant, reacts with oxidized cysteines residues.  S-glutathionylation of troponin I not only 
helps protect the molecule from oxidative stress, but evidently also makes the contractile apparatus 
much more sensitive to calcium ions.  This process seemingly occurs in exercising humans and is 
likely to be an important mechanism helping delay onset of muscle fatigue.          
 
Word count: 150 
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 Abstract 
Oxidation can decrease or increase the Ca
2+
-sensitivity of the contractile apparatus in rodent fast-
twitch (type II) skeletal muscle fibres, but the reactions and molecular targets involved are 
unknown.  This study examined whether increased Ca
2+
-sensitivity is due to S-glutathionylation of 
particular cysteine residues.  Skinned muscle fibres were directly activated in heavily-buffered Ca
2+
 
solutions to assess contractile apparatus Ca
2+
-sensitivity.  Rat type II fibres were subjected to 
S-glutathionylation by successive treatments with 2,2’-dithiodipyridine (DTDP) and glutathione 
(GSH), and displayed a maximal increase in pCa50 (=-log10 [Ca
2+
] at half maximal force) of ~0.24 
pCa units, with little or no effect on maximum force or Hill coefficient.  Partial similar effect was 
produced by exposure to oxidized gluthathione (GSSG, 10 mM) for 10 min at pH 7.1, and near 
maximal effect by GSSG treatment at pH 8.5.  None of these treatments significantly altered Ca
2+
-
sensitivity in rat type I fibres.  Western blotting showed that both the DTDP-GSH and GSSG-pH8.5 
treatments caused marked S-glutathionylation of the fast troponin I isoform (TnIf) present in type II 
fibres, but not of troponin C (TnC) or myosin light chain 2.  Both the increased Ca
2+
-sensitivity and 
glutathionylation of TnIf were blocked by N-ethylmaleimide (NEM).  S-Nitrosoglutathione (GSNO) 
also increased Ca
2+
-sensitivity, but only in conditions where it caused S-glutathionylation of TnIf.  
In human type II fibres from vastus lateralis muscle, DTDP-GSH treatment also caused similar 
increased Ca
2+
-sensitivity and S-glutathionylation of TnIf.  When the slow isoform of TnI in type I 
fibres of rat was partially substituted (~30%) with TnIf, DTDP-GSH treatment caused a significant 
increase in Ca
2+
-sensitivity (~0.08 pCa units).  TnIf in type II fibres from toad and chicken muscle 
lack Cys133 present in mammalian TnIf, and such fibres showed no change in Ca
2+
-sensitivity with 
DTDP-GSH nor any S-glutathionylation of TnIf (latter examined only in toad).  Following 40 min 
of cycling exercise in human subjects (at ~60% peak oxygen consumption), TnIf in vastus lateralis 
muscle displayed a marked increase in S-glutathionylation (~4 fold).  These findings show that 
S-glutathionylation of TnIf, most likely at Cys133, increases the Ca
2+
-sensitivity of the contractile 
apparatus, and that this occurs in exercising humans, with likely beneficial effects on performance. 
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Abbreviations List 
CaEGTA, calcium bound to EGTA; CrP, creatine phosphate;  DTDP, 2,2΄-dithiodipyridine;  EDL, 
extensor digitorum longus;  GSH, reduced glutathione;  GSNO, S-nitrosoglutathione;  HDTA, hexa-
methylene-diamine-tetraacetate;  h, Hill coefficient;  H2O2, hydrogen peroxide;  n, number of fibres;  
NEM, N-ethylmaleimide;  pCa, -log10 [Ca
2+
];  pCa50, pCa producing half maximal force;  pSr50, 
-log10 [Sr
2+
];  pSr50, pSr producing half maximal force;  ROS, reactive oxygen species;  SNAP, S-
nitroso-N-acetyl-penicillamine;  TFP, trifluoperazine;  TnC, troponin C;  TnI, troponin I;  TnT, 
troponin T;  VO2,peak, peak oxygen consumption. 
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Introduction   
Reactive oxygen and nitrogen species are generated in skeletal muscle with normal activity and also 
in pathological conditions, and affect many aspects of muscle function both in the short and long 
term (Smith & Reid, 2006; Supinski & Callahan, 2007; Allen et al., 2008; Powers & Jackson, 2008; 
Lamb & Westerblad, 2011).  Application of hydrogen peroxide (H2O2) to intact fast-twitch muscle 
fibres of the mouse was found to initially cause an increase in force production by increasing the 
Ca
2+
-sensitivity of the contractile apparatus, with prolonged exposure leading to a subsequent net 
decrease in Ca
2+
-sensitivity (Andrade et al., 1998; Andrade et al., 2001).  These effects were fully 
reversible by application of the reducing agent, dithiothreitol (DTT), suggestive that the changes 
involved reversible oxidation of cysteine residues.  Using skinned muscle fibres we have previously 
shown that the increase in Ca
2+
-sensitivity is evidently not due to a direct effect of H2O2 on the 
contractile apparatus, and instead possibly results from the H2O2 interacting with myoglobin and 
reduced glutathione (GSH) within in the fibre (Lamb & Posterino, 2003; Murphy et al., 2008), 
resulting in S-glutathionylation of unknown cysteine residues on the contractile proteins (i.e. RSH 
 RSSG).  This could come about by generation in the cytoplasm of the reactive thiyl radical (GS) 
and/or S-nitrosoglutathione (GSNO) (Dutka et al., 2011b), or simply by the GSH present reacting 
with oxidized cysteine residues on the contractile proteins (see (Lamb & Westerblad, 2011)).  
S-glutathionylation is now recognized as an important mechanism that not only helps prevent 
disruption of protein function by oxidative stress, but also can itself regulate protein function (Klatt 
& Lamas, 2000; Dalle-Donne et al., 2007).  
 
In our previous studies, the presumed S-glutathionylation of the contractile apparatus was mostly 
elicited by treating the skinned fibre with the reactive disulphide, 2,2΄-dithiodipyridine (DTDP) to 
oxidize cysteine residues and then exposing the fibre to GSH for a relatively short period (Lamb & 
Posterino, 2003).  The resulting large increase in Ca
2+
-sensitivity only occurred in fast-twitch (type 
II) fibres, and was reversed by DTT or relatively prolonged exposure to GSH.  The DTDP treatment 
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itself causes a moderate decrease in Ca
2+
-sensitivity (decrease in pCa50 of ~0.065 pCa units), and 
the brief subsequent GSH exposure causes a very large increase in sensitivity (by ~0.28 pCa units), 
resulting in a net increase by ~0.23 pCa units, which is no different from the outcome if the two 
treatments are applied in immediate succession without examining the shift occurring with the 
DTDP treatment alone.  Following reversal by DTT, a repeat of the DTDP-GSH treatment elicits 
virtually identical results.  Similar DTDP-GSH treatment in type I (slow-twitch) rat fibres caused no 
increase in Ca
2+
-sensitivity whatsoever (Lamb & Posterino, 2003).   
 
The aim of the present study was to identify the protein(s) in type II fibres responsible for the 
increased Ca
2+
-sensitivity to DTDP-GSH treatment, verifying by western blotting that this indeed 
involves S-glutathionylation, and if possible also identifying the specific cysteine residues involved.  
The experiments were performed predominantly using skinned muscle fibres, with the first goal 
being to determine whether treatment with oxidized glutathione (GSSG) produced effects similar to 
DTDP-GSH treatment, which would verify that the effects of the latter were not the result of some 
unintended action of DTDP.  As a low concentration of the alkylating agent, N-ethylmaleimide 
(NEM), has been shown to specifically block the increase in Ca
2+
-sensitivity to applied H2O2 in 
intact fibres (Andrade et al., 2001), we examined the ability of NEM to block both the increased 
Ca
2+
-sensitivity and S-glutathionylation of specific proteins.  As the fast isoform of troponin I (TnIf) 
was found to undergo S-glutathionylation in tight accord with the Ca
2+
-sensitivity increase, we 
examined whether substituting TnIf into type I fibres altered their response to DTDP-GSH 
treatment.  We also examined whether the DTDP-GSH treatment affected type II fibres from toad 
and chicken muscle, as the TnIf present in such fibres (Wilkinson & Grand, 1978) lacks one 
particular highly-reactive and accessible cysteine residue present in mammalian TnIf, Cys133 
(Chong & Hodges, 1982; Tao et al., 1990; Park et al., 1994).  Finally, we examined the effect of 
DTDP-GSH treatment in type I and type II fibres from human vastus lateralis muscle and whether 
the glutathionylation state of TnIf was affected in exercise. 
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Methods 
Muscle fibres and samples and ethical approval 
All animal experiments were carried out in accordance with the Australian National Health & 
Medical Research Council’s ‘Australian code of practice for the care and use of animals for 
scientific purposes’, and with approval of the La Trobe University Animal Ethics Committee.  Male 
Long-Evans hooded rats (42 in total, ≥5 months old) were killed by overdose of isoflurane (4 % 
vol./vol.) in a glass chamber, and then the EDL and soleus muscles removed by dissection.  Two 
tropical cane toads (Bufo marinus) that had been maintained at 15°C to lower their activity, were 
stunned and then killed by pithing, and the iliofibularis muscle removed.  Two chickens were killed 
by overdose of intravenous phenobarbitone and a segment of pectoralis major muscle removed. 
 
All protocols and procedures performed with human subjects were approved by the appropriate 
Human Research Ethics Committees at Victoria University, University of Melbourne and La Trobe 
University.  Informed consent was obtained in writing from all subjects and the studies conformed 
to the standards set by the Declaration of Helsinki.  The experiments on the effects of DTDP-GSH 
treatment on human skinned fibres were performed on fibres obtained by muscle biopsy in three 
subjects (two males and one female, 19 – 27 years old, all healthy and recreationally fit).  After 
injection of a local anaesthetic (1% lidocaine) into the skin and fascia, a small incision was made in 
the middle third of the vastus lateralis muscle of each subject and a muscle sample taken using a 
Bergstrom biopsy needle (McKenna et al., 2006).  An experienced medical practitioner took all 
biopsies at approximately constant depth.  The excised muscle sample was rapidly blotted on filter 
paper to remove excess blood and placed in paraffin oil (Ajax Chemicals, Sydney, Australia) at 
10°C for 45 min before individual muscle fibers were dissected.  The effect of exercise on S-
glutathionylation in muscle of human subjects was performed using tissue available from a 
previously published study (Merry et al., 2010).  Briefly, tissue samples were obtained from 5 
healthy, recreationally active male subjects (age 23 ± 2 years) participating in a double-blind 
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randomised cross-over design exercise study with counterbalanced testing order.  A vastus lateralis 
muscle biopsy was obtained as above with the subjects rested, and also on a different date at least 2 
weeks apart after the subjects had completed 40 min of cycling exercise at ~60% of peak oxygen 
consumption (VO2,peak) (see (Merry et al., 2010)).  Muscle samples were frozen in liquid nitrogen 
while still in the biopsy needle within 6–12 s following the cessation of exercise.  Muscle samples 
were stored in liquid nitrogen for later analysis and were obtained from the contralateral leg during 
the second trial. 
 
Preparations and force recording 
Rat and toad whole muscles, and muscle biopsies from human and chicken muscle, were pinned at 
approximately resting length under paraffin oil (Ajax Chemicals, Sydney, Australia) in a petri dish, 
and kept cool (~10°C) on an icepack.  Individual fibre segments were mechanically-skinned with 
jeweller’s forceps and then mounted at 120 % of resting length on a force transducer (AME801, 
SensoNor, Horten, Norway) with a resonance frequency >2 kHz.  The skinned fibre segment was 
then equilibrated for > 2 min in a perspex bath containing 2 ml of relaxing solution (see below).  
Force responses were recorded using a Bioamp pod and Powerlab 4/20 series hardware 
(ADInstruments, Sydney, Australia).  All experiments were performed at room temperature (~23 ±2 
°C).   
 
Skinned fibre solutions  
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated.  
As previously described (Lamb & Posterino, 2003), the ‘relaxing’ solution contained (in mM): 
EGTA, 50; total ATP, 8; creatine phosphate (CrP), 10; Na
+
, 36; K
+
, 126; total Mg
2+
, 8.5; total; 
Hepes, 90; pH 7.1 and pCa >9.  The maximum Ca
2+
-activating solution ‘max’ contained 50 mM 
CaEGTA and had a pCa ~4.7, with total Mg
2+
 adjusted to maintain 1 mM free (see (Stephenson & 
Williams, 1981) for apparent affinity constants).  These two solutions were mixed in appropriate 
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ratio to produce solutions with pCa in the range 6.7 to 4.7.  All solutions had an osmolality of 
295 ±5 mosmol kg
-1
.   Similar strontium-based solutions (with pSr 5.2 = -log10[Sr
2+
] in range >9 to 
4.0) were made by mixing relaxing solution with a Sr-EGTA solution similar to the maximum Ca
2+
-
activating solution.  Exposure to a solution at pSr 5.2 was used to ascertain the predominant 
troponin C (TnC) isoform present (see Results, and (O'Connell et al., 2004; Trinh & Lamb, 2006)).  
Subsequent western blotting was used to confirm the TnC isoform present in all human, chicken, 
toad and some rat fibres.  
 
A 100 mM stock of reduced glutathione (GSH) was made in a potassium HDTA (hexa-methylene-
diamine-tetraacetate) solution similar to the relaxing solution but with all EGTA replaced with 
HDTA; the pH of the stock was re-adjusted to 7.10 with KOH, and then diluted 20-fold to give 5 
mM in the final solution.  A 100 mM stock solution of 2, 2'-dithiodipyridine (DTDP) was made in 
absolute ethanol and diluted 1000-fold in the final solution to 100 µM; matching control solutions 
with the same amount of ethanol (0.1 %) had no noticeably different effect than controls without 
ethanol.  Similarly, NEM was made as a 200 mM or 25 mM stock in ethanol and diluted 1000-fold 
in the final solution.  DTT was added to relaxing solution at 10 mM final concentration from a 1 M 
stock made in double distilled water.   S-nitrosoglutathione (GSNO) can cause either S-nitrosylation 
or S-glutathionylation of a protein thiol.  GSNO was dissolved in solution and either applied 
immediately to the fibre (i.e. within 30 sec, termed ‘GSNOimm’) or applied ~10 min later (i.e. a 10 
min delay, termed ‘GSNOdel’), always with an exposure period of 2 min; it was found that the 
effects of the GSNO treatment was quite different in the two cases.  SNAP (S-nitroso-N-acetyl-
penicillamine, 5 mM) was applied immediately after addition to solution (i.e. within 30 sec).   
 
Except where stated, fibres were never activated in the presence of any of the treatments and were 
simply exposed to each treatment, washed in standard solution/relaxing solution as appropriate, and 
then transferred back into the solutions in which the force responses were elicited. 
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Contractile apparatus experiments and analysis 
The force-Ca
2+
 relationship was determined in each fibre as previously described (Lamb & 
Posterino, 2003; Murphy et al., 2008) by exposing the skinned fibre segment to a sequence of 
solutions heavily-buffered at progressively higher free [Ca
2+
] (pCa >9 to 4.7, the latter eliciting 
maximum force), and then the fibre was fully relaxed again in the relaxing solution.  This procedure 
was performed twice before (‘control’) and twice after each treatment to verify reproducibility and 
also gauge any small changes occurring with repeated activation and over time.  Force produced at 
each [Ca
2+
] within a given sequence was expressed relative to maximum force generated in that 
same sequence, and analyzed by individually fitting a Hill curve to each sequence, for each fibre 
segment, using GraphPad Prism 4 software, yielding separate pCa50 value and h values (pCa at half-
maximum force and Hill coefficient, respectively) for every case.  Maximum force reached in each 
force-[Ca
2+
] sequence was expressed relative to the control level before any treatment in the given 
fibre, after correcting for the small decline occurring with each repetition of the force staircase 
(typically ~2 to 3% in EDL fibres), as gauged from the initial control repetitions in the given fibre 
(see also (Murphy et al., 2008)).  
 
Western blotting  
Non-reducing SDS-PAGE was used for the determination of S-glutathionylation and biotin labeling 
in rat, human and toad fibres, whereas reducing SDS-PAGE was used for the other analyses of rat 
fibres following troponin exchange experiments and other experiments with human, chicken and 
toad fibres.  The S-glutathionylation experiments on rat and toad fibres was based on our previously 
described small-sample methodology (Murphy et al., 2009; Dutka et al., 2011a) with each sample 
consisting of 4 or 5 skinned fibre segments (~60 µg wet wt).  Western blotting of human vastus 
lateralis muscle fibres was performed using the individual skinned fibre segments in which force 
measurements had been made (e.g. Fig. 8).  In all cases the entire fibre constituents were examined 
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without discarding any fraction.  Where multiple skinned fibre segments were examined for 
S-glutathionylation, they were tied together with a silk suture, washed in relaxing solution for at 
least 5 min and then transferred successively to the various treatment solutions as required.  For 
biotin-labeling experiments, following an initial 5 min wash in relaxing solution, individual 
mechanically-skinned EDL fibre segments were treated for either 1 or 5 min with 100 µM EZ-Link 
Biotin-HPDP (ThermoScientific).  Treatment with EZ-Link-Biotin-HPDP results in the formation 
of a disulphide bond between free sulfhydryl (-SH) groups in the fibres and the reagent, resulting in 
a biotin tag on any reacted proteins.  As the last step for all of the above, fibre samples were placed 
in relaxing solution with 5 mM NEM for 5 min to block free sulfhydryl sites and then placed in 
non-reducing buffer for SDS-PAGE (final concentration: 125 mM Tris pH 6.8, 10% glycerol, 4% 
SDS, 0.01% bromophenol blue, 5 mM NEM).  With the troponin exchange experiments (see below) 
(e.g. Fig. 7), the individual soleus skinned fibre segments were mounted on the force transducer and 
force-pCa measurements made before and after the troponin exchange procedure, and then the fibre 
was collected into reducing SDS-PAGE buffer, which was similar to the non-reducing buffer 
described above except the NEM was replaced with the reducing agents urea (4 M) and 
mercaptoethanol (10%).  Total proteins in fibres collected into either buffer was separated on 
various SDS-PAGE gels, (details provided in relevant figure legends, Criterion gels were from 
BioRad, Hercules, CA, USA) and then wet transferred to nitrocellulose for 60 min at 100 V in a 
circulating ice-cooled bath with transfer buffer containing 140 mM glycine, 37 mM Tris-base, and 
20% methanol.  Membranes were then variously probed with anti-GSH (mouse monoclonal, 1 in 
1000, Cat No. 101-A, Virogen, Cincinnati, OH, USA), anti-TnI (rabbit polyclonal, 1 in 1000, Cat 
No. 4002, Cell Signaling Technology, Danvers, MA, USA), TnC (rabbit polyclonal, 1 in 400, Cat 
No. sc-20642, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-myosin light chain 2 (rabbit 
polyclonal, 1 in 200, Cat No. sc-15370, Santa Cruz Biotechnology), anti-actin (rabbit affinity 
isolated, Cat No. A2066, Sigma) all diluted in 1% bovine serum albumin in phosphate-buffered 
saline with 0.025% Tween.  Following exposure to relevant secondary antibodies (or in the case of 
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biotin labeling, to streptavidin (1 in 20,000 in 1%BSA)) and a series of washes in Tris-buffered 
saline with Tween, chemiluminescent substrate (SuperSignal West Femto, Pierce) was applied to 
membranes and Western blot images taken with ChemiDoc XRS fitted with a charge-coupled 
device (CCD) camera using Quantity One software (Bio-Rad).  With the membrane position 
unchanged, the white light source was switched on in order to obtain an image of the prestained 
molecular weight markers on the membrane.  
 
In order to determine the level of S-glutathionylation in whole muscle before and after exercise in 
humans, two to four 10 µm cryosections were cut from each biopsy (Leica 1500 CM1950) and 
placed into microfuge tubes pre-equilibrated to -20°C (number of slices varied to keep total amount 
of tissue approximately the same in all cases).  Cold physiological-based solution with 5 mM NEM 
added was added (10 µl) and the samples kept on ice for 2 min, before non-reducing buffer (see 
above) was added.  Samples were stored at -20°C until analyzed by western blotting, as described 
above.  To confirm that the S-glutathionylation effect could be induced in human muscle and 
measured biochemically, 10 µm sections were cut with the cryostat and placed onto a microscope 
slide.  A circle was drawn around the section with a water repelling ink (Dako, Glostrup, Denmark) 
and the section was then treated with solutions as described for the rat fibres.  Solutions were 
aspirated from the sections prior to the addition of the next solution.  Following all treatment steps, 
the section was collected from the slide in the non-reducing buffer by sucking up into a pipette and 
kept at -20°C until western blotting. 
 
Troponin extraction and exchange.  
All skinned fibres used in the troponin extraction and exchange experiments were first mounted on 
the transducer and then treated with Triton-X100 in relaxing solution (1% vol/vol) for 10 min (and 
then washed in relaxing solution) in order to remove membranous structures and possibly aid 
exchange rates.  Troponin C extraction was achieved by bathing the skinned fibre in a K-EGTA 
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rigor solution with 68 mM EGTA, 5 mM EDTA and 90 mM Hepes (pH to 7.1 with KOH) and no 
added Ca
2+
 or Mg
2+
, plus 0.5 mM trifluoperazine (TFP) (adapted from (Morris et al., 2001)).  The 
fibre was repetitively cycled for 6 min periods between the TFP-rigor solution and relaxing 
solution, for a total exposure to the TFP-rigor solution of 30 min.  This was sufficient to abolish 
>99% of active force to the maximal Ca
2+
-activating solution in type II fibres.  Extraction of both 
troponin C and troponin I was achieved by bathing the skinned fibre in relaxing solution with 
10 mM vandate for 10 min (see (Kogler et al., 1998)).  Following troponin extraction, the skinned 
fibre was bathed for 15 min in relaxing solution with 2 mM DTT and fast troponin either from 
porcine muscle (Sigma, T2275), or rabbit muscle (Ocean Biologicals Inc, Seattle, WA, USA), the 
latter applied as TnC alone, or equal part mixtures of TnI and TnT, or TnC, TnI and TnT (3 to 
10 mg/ml).  Troponin exchange (without initial troponin extraction) was achieved by bathing the 
skinned fibre segment for 1 hr in a low ionic strength rigor solution with zero Ca
2+
 and Mg
2+
 (mM: 
EGTA, 2.5; EDTA, 2.5; Hepes, 10, pH 7.1 with KOH) with porcine or rabbit fast troponin 
(10 mg/ml) and 2 mM DTT. 
 
Statistics 
Values are presented as mean ± standard error of the mean (s.e.m.) (or mean ± s.d., the sample 
standard deviation, where n = 2), with n denoting the number of fibres examined.  Statistical 
significance (P<0.05) was determined with Student’s two-tailed paired t-test, or where values were 
not normally distributed by the Wilcoxin signed rank test.  Data where n=2 were not examined 
statistically.
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Results 
Effects of treatment with DTDP-GSH or GSSG 
In agreement with our previous findings (Lamb & Posterino, 2003), when a skinned type II fibre 
from rat EDL muscle was treated sequentially with DTDP (100 µM) for 5 min and then GSH 
(5 mM) for 2 min (denoted as the ‘standard’ DTDP-GSH treatment, all applied in relaxing solution, 
pCa >9), the Ca
2+
-sensitivity of the contractile apparatus was greatly increased, as seen with the 
final treatment in Figure 1A.  In the 18 EDL fibres examined, the pCa50 was increased on average 
by ~0.24 pCa units (row 1 in Table 1), with only a slight decrease in the Hill coefficient (h) 
(-11 ± 4%, from ~5.5 to 5.0) and no detectable change in maximum Ca
2+
-activated force.  The 
effects of the DTDP-GSH treatment were fully reversed with the reducing agent, DTT (Table 1).  
The DTDP-GSH treatment had the exactly same effects in fibres treated with Triton-X100 (not 
shown), indicating that it acted directly on the contractile apparatus.  Type II fibres obtained from 
rat soleus muscle, which are almost exclusively type IIA fibres (Bortolotto et al., 2000; O'Connell 
et al., 2004), showed exactly the same effects to DTDP-GSH as the EDL type II fibres (not shown). 
 
The effect of the DTDP-GSH treatment was not noticeably different with DTDP (100 µM) 
exposures of between 30 s and 5 min, and with GSH (5 mM) exposures of between 30 s and 2 min 
(all applied at pCa >9 without fibre activation).  If the exposure time to DTDP was made even 
shorter, the increase in pCa50
 
was smaller, with a 5 s exposure causing only ~38 and 43% of the 
maximal shift, and a 10 s exposure causing ~51 and 57%, in the 4 EDL fibres examined.  Sr
2+
 ions 
activate the TnC isoform present in fast-twitch fibres, but only at ~20 fold higher concentration than 
for Ca
2+
 (Lynch et al., 1995; O'Connell et al., 2004; Trinh & Lamb, 2006), and it was found that the 
DTDP-GSH treatment increased the Sr
2+
-sensitivity to a similar extent as the Ca
2+
-sensitivity 
(maximal increase in pSr50 +0.280 ± 0.013, and in pCa50 +0.241 ± 0.012 in above 4 fibres, and with 
similar proportional shift in pSr50 with the shorter DTDP exposures).  At much higher concentration 
(e.g. 1 mM) DTDP treatment results in reduction in maximal force and Ca
2+
-sensitivity in both type 
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II and type I fibres (Lamb & Posterino, 2003), probably by oxidizing cysteine residues on additional 
types of proteins. 
 
In order to examine whether the effects of the standard DTDP-GSH treatment were attributable to 
S-glutathionylation, and not dependent on some additional effect of the initial DTDP oxidizing step, 
we compared the effects of oxidized glutathione (GSSG) as an alternative method of producing 
S-glutathionylation.  We previously found that a 5 min exposure to 2.5 mM GSSG produced no 
significant change in Ca
2+
-sensitivity (average +0.004 pCa units in two EDL fibres) (Lamb & 
Posterino, 2003), and consequently here examined the effects a longer exposure at higher 
concentration.  In the 3 EDL fibres examined, a 10 min exposure to 10 mM GSSG at pH 7.1 
increased pCa50 by a mean of +0.055 ± 0.010, which is ~25% of the maximal DTDP-GSH effect.  
The ability of GSSG to S-glutathionylate a protein cysteine (RSH) is considerably enhanced if the 
latter is in its thiolate anion form (RS
-
) (Klatt & Lamas, 2000; Dalle-Donne et al., 2007), which is 
favoured by increasing the solution pH, and so we next tested the effect of applying GSSG at 
pH 8.5 for 10 min.  As such exposure at pH 8.5 itself causes a ‘once-off’ reduction in Ca2+-
sensitivity and maximum force in rat soleus fibres (Dutka et al., 2011a), each EDL fibre was first 
subjected to the pH 8.5 conditions without GSSG, which resulted in reductions in pCa50 (by 
-0.079 ± 0.009 pCa units), h (by 34 ± 5%, n=12), and maximum force (by 6 ± 1%) (e.g. see Fig. 1).  
A repeated exposure to pH 8.5 conditions had virtually no further effect (not shown).  However, as 
seen in Figure 1, when 10 mM GSSG was present in the pH 8.5 solution, there was a very marked 
increase in the Ca
2+
-sensitivity (mean increase in pCa50 ~+0.19, row 4 in Table 1), with little or no 
change in either h or maximum force.  This increase in Ca
2+
-sensitivity was fully reversed by the 
standard DTT treatment (10 mM, 10 min), returning the level to approximately that present after the 
initial pH 8.5 exposure (Table 1).   
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When the standard DTDP-GSH treatment was applied after the 10 min GSSG-pH8.5 treatment, it 
resulted in little further increase in Ca
2+
-sensitivity, but if the sensitivity increase was first reversed 
with DTT, DTDP-GSH treatment caused its usual large effect (see Fig 1).  If however the DTDP-
GSH treatment was applied following a submaximal GSSG treatment (i.e. 10 mM GSSG at pH 7.1, 
or 2.5 or 5 mM GSSG at pH 8.5), it caused a further increase in Ca
2+
-sensitivity, but the net effect 
of the two sequential treatments (total shift of pCa50 ~0.23) was still just the same as occurred with 
the DTDP-GSH treatment alone (Figure 2).  All effects were fully reversed by DTT.  These data 
strongly suggest that the DTDP-GSH and GSSG treatments increase Ca
2+
-sensitivity by the same 
mechanism, that presumably being by S-glutathionylation. 
 
Effects of treatments in type I fibres 
Skinned fibres obtained from rat soleus muscle were designated as type I or type II according to 
their response to Sr
2+
 (see Methods); type I fibres contain almost exclusively only the slow isoforms 
of troponin (e.g. see Fig. 7 later) and are relatively sensitive to activation by Sr
2+
, whereas the type 
II fibres contain fast troponin isoforms and are relatively insensitive to Sr
2+
 (Lynch et al., 1995; 
O'Connell et al., 2004).  In contrast to all rat type II fibres examined, rat type I fibres showed no 
significant change in sensitivity with either the DTDP-GSH treatment or the GSSG-pH 8.5 
treatment (rows 6 & 7 in Table 1).  Table 1 shows the changes in pCa50 occurring with the various 
treatments, as well as the effect of subsequent DTT treatment.  It should be borne in mind that 
subjecting skinned fibres to repeated force-pCa measurements itself results in a small progressive 
decrease in Ca
2+
-sensitivity (and maximum force) even without any treatment, with the shift being 
on average ~-0.012 pCa units per pair of force-pCa ‘staircases’ (see also (Lamb & Posterino, 2003; 
Murphy et al., 2008)).  It is apparent that the DTDP-GSH and GSSG-pH 8.5 treatments had no 
detectable effect on pCa50 in rat type I fibres. 
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Effect of DTDP-GSH treatment during activation in type II fibres  
All of the above treatments were applied with the fibres in the relaxed state (at pCa >9), and it was 
important to also consider whether the effect was any different in an activated fibre.  Applying 
DTDP to type II fibres during submaximal activation affects Ca
2+
-sensitivity (increase in pCa50 by 
~0.05 pCa units, and decrease in h) in a different manner to that when applying the DTDP with the 
fibre relaxed (decrease in pCa50 by ~0.065 pCa units) (Lamb & Posterino, 2003), possibly because 
the activation allows access to additional cysteine residues or interaction between relocated 
proteins.  This activation-dependent effect appeared to be independent of the action of DTDP-GSH 
(Lamb & Posterino, 2003), but the combination of actions potentially complicates interpretation.  
Importantly, it was found here that when DTDP was applied (for 15 s) whilst the fibre was 
maximally activated (in pCa 4.7), it had effects similar to those in a resting fibre, decreasing pCa50 
by ~0.08 pCa units.  This made it possible to readily compare the effects of DTDP-GSH treatment 
in the rested and maximally-activated states.  DTDP was applied for only 15 s and then GSH for 
only 30 s in order to minimize the time the fibre was maintained in the maximally-activated state 
(which leads to irreversible decrement in force if very prolonged).  It was found that such DTDP-
GSH treatment produced virtually the same increase in Ca
2+
-sensitivity irrespective of whether it 
was applied with the fibre relaxed (+0.206 ± 0.020 pCa units) or maximally activated 
(+0.197 ± 0.018 pCa units) (both treatments examined in same three type II EDL fibres).   
 
Block by NEM 
Andrade et al (2001) found in intact fast-twitch fibres that a 3 min exposure to 25 µM of NEM 
blocked the increase in contractile sensitivity that otherwise occurs with H2O2 application, without 
the reductions in maximal force that occur with higher [NEM], or longer exposure (Perkins et al., 
1997).  It was found here that exposing type II EDL fibres for 2 min to 25 µM NEM (at pCa >9) 
blocked >85% of the increase in Ca
2+
-sensitivity occurring with the DTDP-GSH and GSSG-pH 8.5 
treatments (Table 1, rows 2 & 5) (e.g. Figure 3).  The NEM treatment itself caused only a minor 
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decrease in maximum force (-2.3% ± 0.7%) and Ca
2+
-sensitivity (pCa50 -0.047 ± 0.008 pCa units) 
(n=7).  As expected, none of the effects of the alkylating agent NEM were reversed by DTT.   
 
Western blotting for S-glutathionylation 
Western blotting under non-reducing conditions was performed using groups of 5 EDL fibre 
segments rather than single segments (see Methods), owing to the low sensitivity of anti-GSH 
antibody used to detect S-glutathionylation.  An anti-GSH signal for a protein running at ~23 kDa 
was observed for all fibre samples subjected to the standard DTDP-GSH treatment, with little 
matching signal apparent in untreated (control) fibres or in fibres treated with DTT (e.g. Fig 4A 
&B).  Reprobing the membranes with anti-TnI showed the 23 kDa band corresponded with the 
position of the fast isoform of TnI (TnIf) in every case.  The density of the anti-GSH signal for TnIf 
(normalized to the corresponding TnIf density) was ~4 times greater in the DTDP-GSH treated 
fibres relative to the control fibres (Fig. 4C) fibres; these data were obtained from a total of 11 
independent gels and DTDP-GSH treated samples, comparing matching control samples collected 
in the same experiments in 10 of these cases.  The anti-GSH/TnIf ratios for other treatment samples 
run on a subset of the same gels, expressed relative to DTDP-GSH case (defined as ‘1’), were 
0.38 ± 0.26 (s.d., n=2) for samples treated with just DTT, and 0.53 ± 0.07 (n=4) for fibres treated 
with DTDP-GSH and then DTT, and 0.31 ± 0.18 (n=3) for fibres pretreated with NEM and DTT 
before DTDP-GSH.  The latter two cases were significantly lower than for the DTDP-GSH 
treatment alone (Fig. 4C), consistent with DTT reversing the effect of DTDP-GSH treatment and 
with NEM blocking its action.  Treatment of fibres with GSSG-pH 8.5 also increased the anti-GSH 
signal relative to control.  In the two cases examined, the anti-GSH/TnIf ratio expressed relative to 
the DTDP-GSH case run on the same gel was 0.3 ± 0.1 for the control treatment and 2.0 ± 0.2 for 
the GSSG-pH 8.5 treatment.  
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Most membranes were also reprobed for actin, and it was found that the TnIf signal expressed 
relative to either the actin signal or the MHC signal (see Methods) was not significantly altered by 
any of the treatments.  The anti-GSH blots invariably also showed strong signals corresponding to 
actin (e.g. Fig. 4A), but these signals were not noticeably different between the control and 
treatment cases.  The only other band where the anti-GSH signal was often evidently more intense 
for the DTDP-GSH treated samples relative to control was seen at ~100 kDa and possibly 
corresponded to the SR Ca-ATPase, which is known to undergo S-glutathionylation (Viner et al., 
1999).    
   
Additional experiments were also performed that avoided any possible problems arising with 
reprobing of membranes (e.g. probing first with anti-GSH and then with anti-TnI, as in Figure 4).  
In these experiments, treated EDL fibre samples were divided in three equal parts, which were run 
on three separate gels, with one each being first probed for either anti-GSH, anti-TnI or anti-TnC.  
These experiments (not shown) gave results indistinguishable from those obtained by the reprobing 
procedure, demonstrating that the anti-TnIf signal was accurately assessed by the reprobing method 
and further verifying that the DTDP-GSH treatment increases the anti-GSH/TnIf ratio.  Importantly 
too, neither type of blotting procedure (e.g. Fig 4 A & B) found any apparent anti-GSH signal 
corresponding to either TnCf or myosin light chain 2 (MLC), which both run at ~18 kDa.  (Note that 
fast TnT isoforms were not examined as they do not contain cysteine residues and hence cannot 
undergo S-glutathionylation).  The experiments also found no evidence of any appreciable cross-
linking of TnIf and TnCf either to each other or to actin, as only single bands were found when 
probing for TnI or TnC (at ~23 and 18 kDa, respectively).  In summary, both western blotting 
methods indicated that the DTDP-GSH and GSSG-pH 8.5 treatments cause S-glutathionylation of 
TnIf. 
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Biotin labeling of reactive cysteine residues 
The reactivity of the free cysteine groups present in an EDL muscle fibre in relaxing conditions was 
examined using a reactive thiopyridine reagent (Biotin-HPDP) with a biotin tag that can be detected 
with high sensitivity.  As seen in Figure 5, a one minute exposure to the reagent produced 
appreciable biotin labeling of TnIf as well as labeling of actin and a protein running at ~105 kDa 
(possibly the SR Ca-ATPase).  Longer exposure to the reagent gave stronger labeling of these 
proteins as well as of MHC and some other proteins.  Taking into account the relative amounts of 
each protein present in a muscle fibre, the comparatively strong labeling to TnIf seen with the 1 min 
exposure to Biotin-HPDP confirms that one or more cysteine residues present on TnIf in situ on the 
thin filament in relaxing conditions is exposed and relatively reactive to thiopyridine reagents.  
Furthermore, the absence of any biotin labeling at ~18 kDa even with the more prolonged reagent 
exposure indicates that the cysteine residues present in TnCf and MLC2 are inaccessible or 
comparatively unreactive in a fibre in relaxing conditions. 
 
S-glutathionylation of TnIf by GSNO 
GSNO can potentially cause either S-glutathionylation or S-nitrosylation of a given cysteine 
residue.  We have previously reported (Dutka et al., 2011b) that when GSNO (2 mM) is applied to a 
skinned EDL fibre immediately after being prepared in solution (termed GSNOimm) it causes a large 
increase in Ca
2+
-sensitivity (~+0.14 pCa units), seemingly by the same mechanism as occurs with 
DTDP-GSH treatment.  In contrast, if GSNO is applied to the fibre ~10 min after preparation 
(termed GSNOdel) it instead causes a decrease in Ca
2+
 sensitivity (~ -0.06 pCa units), seemingly in a 
manner similar to the S-nitrosylating agent, SNAP.  As seen in Figure 6, western blotting showed 
that GSNOimm caused S-glutathionylation of TnIf, whereas GSNOdel treatment did not.  Very similar 
results were found in all three independent examinations conducted. 
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Troponin exchange experiments 
To further examine whether S-glutathionylation of TnIf is mechanism underlying the increase in 
Ca
2+
-sensitivity, we tested whether substituting fast troponin isoforms into slow-twitch (type I) 
muscle fibres made them responsive to the DTDP-GSH treatment.  The procedures attempted on rat 
skinned fibres were a) to extract just the endogenous TnC and then to add exogenous fast TnC from 
either porcine or rabbit muscle, b) to extract both TnC and TnI and then to add the exogenous fast 
isoforms, or c) to substitute the endogenous TnC and TnI (and probably TnT) without first going 
through a specific extraction step (see Methods).  
 
TnC extraction and re-addition.   TnC extraction was achieved by exposing a skinned fibre for 
30 min to a rigor solution of normal ionic strength with TFP and no Ca
2+
 or Mg
2+
.  This resulted in 
complete loss of Ca
2+
-activated force in the 8 EDL type II fibres and its reduction to between 1 - 
4% of the original level in the 4 soleus type I fibres examined, with no change in baseline Ca
2+
-
independent force.  Western blotting in subset of these and other fibres confirmed extraction of 80 
to 100% of the TnC, with relatively little if any change in TnI (not shown).  After the fibres had 
been bathed for 15 min in relaxing solution containing exogenous fast troponins (i.e TnC, TnI and 
TnT) from either rabbit or porcine muscle, maximum force recovered to 56 ± 3% and 39 ± 1% of its 
original value in type II (n=6) and type I (n=4) fibres respectively.  Almost exactly the same level of 
recovery was seen in two type II fibres when adding TnCf alone, indicating that the reduction in 
maximum force had been primarily due to the loss of TnC.  Following the extraction and 
replacement of TnC, the Ca
2+
-sensitivity of the fibres was substantially altered: pCa50 decreased by 
~0.21 to 0.26 pCa units in the type II fibres and by ~0.35 to 0.44 pCa units in the type I fibres and h 
decreased ~50% in all cases, with no apparent difference between the porcine and rabbit TnCf.  The 
pCa50 is normally ~0.16 pCa units higher in rat type I fibres compared to type II fibres (Trinh & 
Lamb, 2006), but after substituting TnCf into both fibres types this difference disappeared. 
 
22 
 
Following the TnCf substitution, DTDP-GSH treatment increased pCa50 by +0.187 ± 0.026 pCa 
units in the 4 type II fibres examined, demonstrating that its normal action still occurred.  In 
contrast, in two other type II fibres where the endogenous TnC was extracted and the fibre exposed 
to 25 µM NEM for 2 min before washing and adding exogenous TnCf, subsequent DTDP-GSH 
treatment caused only ~5% of its usual increase in Ca
2+
-sensitivity shift (+0.011 ± 0.002 SD), 
indicating that type II fibres were affected by NEM treatment even when TnCf was largely absent.  
In the type I fibres following TnCf substitution, DTDP-GSH treatment still failed to cause any 
significant change in pCa50 (+0.021 ±0.007, n=4, P>0.05); western blotting of one of these type I 
fibres verified that most (though not all) of the slow TnC had indeed been replaced with the fast 
isoform. 
 
TnI and TnC extraction and re-addition.   Combined extraction of both TnC and TnI (and possibly 
some TnT) was achieved by bathing a fibre in relaxing solution with 10 mM vanadate for 10 min 
(Kogler et al., 1998).  No force was produced in the presence of the vanadate, but upon washout 
with relaxing solution force developed over several minutes in a Ca
2+
-independent manner, 
reaching a peak of 31 ± 3% of the original Ca
2+
-activated maximum force in type II fibres (n=12) 
and 62 ± 6% in type I fibres (n=7).  This Ca
2+
-independent force was suggestive of at least partial 
TnI extraction, and western blotting of some fibres confirmed such partial extraction (not shown).  
Subsequent exposure of the fibre either to a mixture of TnC, TnI and TnT (fast isoforms), or to just 
TnI and TnT, resulted in the Ca
2+
-independent force declining to zero in the type II fibres and to ~2 
to 6% of the original maximum Ca
2+
-activated force in the type I fibres.  Ca
2+
-activated force only 
recovered if TnC was added with the TnI and TnT or alternatively added subsequently.  Maximum 
force recovered to ~55 to 60% of the original level in the 3 type II fibres examined, but to only 
17 ± 3% in the type I fibres (n=7), which along with the partial nature of the troponin exchange, 
precluded meaningful examination of the effects of DTDP-GSH treatment in such fibres.    
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Troponin substitution without prior extraction.   As extraction and subsequent replacement of the 
troponins appeared to lead to poor recovery of maximum force, troponin exchange was instead 
performed by exposing the skinned fibres to the exogenous troponins in the presence of a low ionic 
strength solution with zero Ca
2+
 and Mg
2+
 (see Methods); such low ionic strength likely aids 
unbinding of TnT, allowing it to also be substituted, and possibly even allowing exchange of the 
entire endogenous slow troponin trimer complex with the exogenous fast troponin complex.  
Following 60 min of such exposure, maximum Ca
2+
-activated force back in standard conditions was 
still 92 to 96% of the original maximum in the 5 type I rat fibres examined (3 with porcine and 2 
with rabbit troponin exposure).  
 
However, in contrast to what occurred when exchanging just TnCs with TnCf (where pCa50 was 
decreased after extraction and addition using either rabbit or porcine TnCf (see above)), exchanging 
the TnI/TnT by either the vanadate treatment-replacement protocol or the low ionic strength 
exchange, resulted in a decrease in Ca
2+
-sensitivity when adding rabbit troponins (pCa50 
-0.12 ± 0.03 in 5 type I fibres and -0.20 ± 0.02 in 11 type II fibres) but a large increase when adding 
porcine troponins (pCa50 +0.47 ± 0.03 in 5 type I fibres and +0.17 ± 0.04 (s.d.) in 2 type II fibres).  
Such data are consistent with the fact that TnCf is virtually identical in rat, rabbit and pig, whereas 
the TnIf isoforms present differ slightly between the three species, as well as the fact that at least 
three distinct variants of fast TnT are found in type II fibres even in a single species (Brotto et al., 
2006).   
  
Most importantly, following substitution of TnIf into soleus type I fibres, DTDP-GSH treatment 
resulted in an increase in Ca
2+
-sensitivity, as seen in Figure 7A & B.   In this experiment the force-
pCa characteristics were examined after applying the DTDP and then again after applying GSH, in 
order to remove the confounding effects of the DTDP treatment itself and directly determine 
whether the GSH exposure caused a reversible increase in sensitivity.  In the 3 type I fibres 
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examined following porcine TnIf substitution, GSH treatment caused a substantial increase in Ca
2+
-
sensitivity (~ +0.126 pCa units), which was fully reversed by DTT (Table 2), whereas normal type I 
fibres show no significant effect to such treatment (results here and also Lamb & Posterino (2003) – 
see Table 2), with one of these control cases being one of the three fibres subsequently shown to 
undergo a large increase in Ca
2+
-sensitivity after troponin exchange.  Western blotting of the type I 
fibre shown in Figure 7A indicated that ~35% of TnIs originally present in the fibre had indeed been 
substituted with TnIf (lane 2 in Figure 7C).  This estimate of percentage exchange was based on the 
evident reduction in the intensity of the TnIs band in lane 2 relative to the bracketing untreated 
fibres run on either side (lanes 1 & 3) (taking into account the sample mass in each lane indicated 
by the MHC bands shown at the top), together with the fact that non-linearity in the signal detection 
of the bands evidently resulted in disproportionately weak signals for smaller TnI amounts (which 
also likely precluded detection of any substituted TnIf in the relatively small sample in lane 4) (see 
also (Murphy et al., 2009)).  The reversible increase in Ca
2+
-sensitivity with DTDP-GSH treatment 
also appeared to occur in the two type I fibres examined following exchange with rabbit troponin 
(Table 2), albeit to a smaller extent than with the porcine troponin exchange.   
 
Effects of DTDP-GSH treatment in human muscle fibres 
The effect of DTDP-GSH treatment was also examined in human vastus lateralis muscle fibres.  
Each fibre was classified as either type I or II both by its response to Sr
2+
 (see Methods) and by 
subsequent western blotting for MHC, TnC and TnI (e.g. Fig 8B), the results of which were in 
complete accord for each of the 5 fibres examined.  All three of the human type II fibres examined 
(obtained from three different subjects) showed a large increase in Ca
2+
-sensitivity with DTDP-
GSH treatment (~ +0.171 pCa units, row 8 in Table 1), which was fully reversed by DTT (e.g. Fig 
8A).  In contrast, none of the 3 type I human fibres examined showed any increase in Ca
2+
-
sensitivity to DTDP-GSH, instead displaying a decrease in every case (mean change in pCa50 of -
0.111 ± 0.006 pCa units,) with subsequent DTT treatment increasing Ca
2+
-sensitivity (+0.053 ± 
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0.014 pCa units); this effect of the DTDP-GSH treatment was largely or entirely attributable to the 
effects of the DTDP treatment alone, as seen in Figure 8C.  The 5 min DTDP treatment appeared to 
have greater effects in human fibres than it did in rat fibres, reversibly decreasing maximum force 
by 5 to 15%, which was similar to that seen in rat fibres with more prolonged treatments or higher 
[DTDP] (see (Lamb & Posterino, 2003)).  In summary, the results with human muscle closely 
resemble those in rat, with only the type II fibres showing increased Ca
2+
-sensitivity to the DTDP-
GSH treatment.   
 
TnIf in human muscle is highly homologous to that in other mammals, and as seen in Figure 9A it 
also undergoes S-glutathionylation upon DTDP-GSH treatment.  The slow isoform of TnI, TnIs, is 
also S-glutathionylated by the DTDP-GSH treatment in both human muscle (Fig 9A, see presence 
of two bands with anti-GSH) and rat soleus muscle (not shown).  Figure 9A also illustrates two 
other important points.  Firstly, the TnIf in rested human muscle shows some base level of 
S-glutathionylation (see lane 3).  Secondly, S-glutathionylation of TnIf causes the TnIf to run 
slightly slower (i.e. at slightly higher apparent molecular mass) in both rat (lane 2 versus 1) and 
human muscle (lane 4 versus 3).  Close inspection of all gels where TnIf underwent 
S-glutathionylation consistently showed this small effect (e.g. Fig.s 4, 5, 6 & 10), though it was 
most apparent when precisely matched samples were compared as in Figure 9A.  One result of this 
is that when only a portion of the total TnIf in a sample is S-glutathionylated, the latter forms the 
trailing (or upper) part of the TnIf band seen with anti-TnI (e.g. lower panel in Fig. 9A), and 
because only it is seen with anti-GSH (middle panel in Fig 9A) the anti-GSH bands for TnIf and 
TnIs appear closer together than do the anti-TnI bands for the two proteins.  (Note that this effect is 
in part due to the fact that TnIs evidently does not run any slower when glutathionylated).  
Importantly, the fact that the TnIf band can be seen to run slower following the DTDP-GSH 
treatment is further strong evidence that the TnIf is indeed affected by the treatment and is correctly 
identified as being the S-glutathionylated protein apparent on the anti-GSH blots.   
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Effect of DTDP-GSH treatment in toad and chicken type II fibres 
TnIf in most if not all mammalian species has three cysteine residues, Cys48, Cys64 and Cys133, 
and in the troponin complex only Cys133, which is highly reactive, is accessible to applied 
reactants (Chong & Hodges, 1982), as illustrated in Figure 9B.  Therefore it can be presumed that 
the S-glutathionylation of TnIf occurs at Cys-133.  Consistent with this, mammalian TnIs lacks an 
equivalent of Cys133; it has a Cys65 residue homologous to Cys64 in TnIf, as well as two other 
cysteine residues (Cys38 and Cys85) that are quite distinct from those in TnIf.  The reactivity and 
accessibility of the cysteine residues in TnIs have not been described, but the results here indicate 
that at least one of the residues, possibly Cys38 or Cys85, is accessible and becomes 
S-glutathionylated with DTDP-GSH treatment. 
 
TnIf in chicken and toad muscle are highly homologous to mammalian TnIf except that they both 
lack the equivalent of Cys133 (Wilkinson & Grand, 1978).  Type II fibres were obtained from 
iliofibularis muscle of the toad and the pectoralis major muscle of the chicken and all showed the 
expected low sensitivity of Sr
2+
 (O'Connell et al., 2006) and fast TnC and TnI bands on western 
blotting (not shown).  Importantly, DTDP-GSH treatment caused no significant change in Ca
2+
-
sensitivity in either the chicken or toad type II fibres (rows 9 and 10 in Table 1), consistent with the 
increased Ca
2+
-sensitivity occurring in mammalian muscle being due to S-glutathionylation of 
Cys133.  (In the chicken and toad fibre experiments listed in Table 1, the DTDP exposure was 
reduced from 5 min to 1 min, because the longer exposure to DTDP itself resulted in a moderate 
reduction in maximum force and Ca
2+
-sensitivity particularly in the chicken fibres; importantly, 
GSH exposure following the longer DTDP treatment still did not cause any increase in Ca
2+
-
sensitivity in any of the fibres examined).   
 
Furthermore, DTDP-GSH treatment did not cause any S-glutathionylation of TnIf in toad type II 
fibres, as seen in Figure 10.  Note that the anti-GSH band detected in the toad fibres in a similar 
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position to TnIf in the rat fibres is an unknown protein and does not correspond to the TnIf in the 
toad fibres, which was shown on the TnI reprobe to run somewhat lower.  The full anti-GSH blot 
presented in Figure 10 shows that there are a number of S-glutathionylated proteins present in the 
toad fibres that are not present in the rat fibres.  Importantly, it also shows that the TnIf was the only 
protein present in these rat type II fibres with a noticeable change in S-glutathionylation upon 
DTDP-GSH treatment.  
 
S-glutathionylation of TnIf in exercising humans 
Finally, we examined whether the level of S-glutathionylation of TnIf in human muscle was 
affected by exercise (see Methods).  We found that there was a ~4 fold increase in the level of 
S-glutathionylation of TnIf in vastus lateralis muscle of 5 human subjects following 40 min of 
cycling exercise at ~60% VO2,peak
 
(Fig 11).  
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Discussion                                    
This study provides compelling evidence that TnIf in mammalian fast-twitch (type II) fibres can be 
readily S-glutathionylated and that this results in a relatively large increase in Ca
2+
-sensitivity of the 
contractile apparatus with no detectable change in maximum force.  The maximal effect was a 
~ +0.24 pCa unit increase in pCa50 (Table 1), which corresponds to a 1.7 fold decrease in [Ca
2+
] 
needed for half-maximal force.  We previously showed that treating rat type II fibres with DTDP 
and then briefly (1 to 2 min) with GSH produces this increase in Ca
2+
-sensitivity, and that this could 
be reversed by DTT or much longer (>20 min) exposure to GSH, effects, strongly suggesting that 
the key process involved S-glutathionylation of some unidentified contractile apparatus protein 
(Lamb & Posterino, 2003).  It was found here that a 10 min exposure to oxidized glutathione 
(GSSG) had the same action, and produced approximately the same maximal effect if applied at 
pH 8.5 (Fig.s 1 & 2, Table 1), the latter being used as a means of increasing the reactivity of the 
cysteine residues (Klatt & Lamas, 2000; Dalle-Donne et al., 2007).  Western blotting showed that 
both the DTDP-GSH and GSSG-pH 8.5 treatments caused S-glutathionylation of TnIf in every 
instance examined (e.g. Fig.s 4, 9 & 10), without having any apparent effect on the other possible 
target proteins, in particular TnCf or myosin light chain 2.  The only other protein seen in many 
instances to display increased S-glutathionylation with the DTDP-GSH treatment was a protein of 
~100 kDa, which was likely to be the SR Ca
2+
 pump (Viner et al., 1999).  Effects on the Ca
2+
 pump 
could not account for the increased sensitivity of the contractile apparatus, particularly given that 
the increased Ca
2+
-sensitivity still occurred even after removal of all membranes with the detergent 
Triton-X100.  Western blotting further demonstrated that there was no appreciable level of cross-
linking of TnIf with TnCf or other proteins upon DTDP-GSH treatment.  Treatment with GSNO can 
cause either increased or decreased Ca
2+
-sensitivity depending on how it is applied (Dutka et al., 
2011b), and it was found here that the increase in Ca
2+
-sensitivity occurred only when TnIf was 
S-glutathionylated (Fig. 6).  Finally, DTT treatment reversed both the increase in Ca
2+
-sensitivity 
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and the S-glutathionylation of TnIf, and NEM pre-treatment blocked both effects (Fig.s 3 & 4 & 
Table 1). 
  
Type I fibres lack TnIf, instead having the slow isoform TnIs, and these fibres show no increase in 
Ca
2+
-sensitivity to either DTDP-GSH treatment or GSSG-pH 8.5 treatment (Table1).  Crucially, 
after TnIs was partially substituted with TnIf, the type I fibres did show increased Ca
2+
-sensitivity 
upon DTDP-GSH treatment (Fig. 7 & Table 2), strongly implicating TnIf as the crucial mediator of 
the effect.  The effects could not have been mediated by TnTf, because there are no cysteine 
residues in any of the three mammalian variants of TnTf and hence they cannot undergo 
S-glutathionylation.  It was also apparent that the effects were not mediated by TnCf, because i) as 
mentioned above, TnCf did not become S-glutathionylated with DTDP-GSH treatment, ii) the Ca
2+
-
sensitivity increase with DTDP-GSH treatment takes place even when a fibre is maximally 
activated by Ca
2+
, which is known to make the one cysteine residue on TnCf (Cys98) inaccessible 
(Park et al., 1994), iii) specific extraction of TnCs and replacement with TnCf did not cause type I 
fibres to display increased Ca
2+
-sensitivity with DTDP-GSH, and iv) type II fibres treated with 
NEM whilst largely devoid of TnCf showed virtually no Ca
2+
-sensitivity increase to DTDP-GSH 
following re-insertion of TnCf.  Furthermore, the biotin-HPDP labeling experiments (e.g. Fig. 5) 
indicated that the cysteine on TnCf was inaccessible or poorly reactive to thiopyridine reagents.  
 
Cysteine target on TnIf 
Mammalian TnIf has three cysteine residues (see Fig. 9B), but when TnIf is in the troponin complex 
with TnC and TnT only Cys133 is accessible and reactive, and this is the case in both the presence 
and absence of Ca
2+
 (Chong & Hodges, 1982).  Thus, the S-glutathionylation of TnIf observed here 
is only attributable to an action on Cys133.  Furthermore, the finding here that the increase in Ca
2+
-
sensitivity with DTDP-GSH treatment was the same in both resting and activated fibres, is fully 
consistent with the known accessibility of Cys133.  The fact that the sensitivity shift to DTDP-GSH 
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treatment remained the same after replacement of TnIf in rat type II fibres with either porcine or 
rabbit TnIf is also consistent with Cys133 being the key target, as it is present in all these variants of 
TnIf.  This cysteine residue is likewise present in the TnIf of human type II fibres, which also show 
the Ca
2+
-sensitivity increase to DTDP-GSH (Fig. 8A).  Type II fibres from toad and chicken, on the 
other hand, have fast isoforms of TnI and TnC that are highly homologous to mammalian TnIf and 
TnCf
 
, having matching cysteine residues to Cys98 in TnCf, and to Cys 48 and Cys64 in TnIf, but 
they lack the equivalent of Cys133, having an asparagine residue in its place (Wilkinson & Grand, 
1978).  Significantly, neither toad nor chicken type II fibres showed any change in Ca
2+
-sensitivity 
with DTDP-GSH treatment (Table 1), and western blotting of TnIf in toad fibres showed no 
detectable S-glutathionylation, either with or without DTDP-GSH treatment (Fig. 10).  These 
findings together strongly implicate S-glutathionylation of Cys133 on TnIf as being the process 
responsible for the increased Ca
2+
-sensitivity occurring with DTDP-GSH treatment. 
 
Cys133 on TnIf is located in a highly flexible and mobile domain of the protein which can oscillate 
back and forth between actin and TnC (Aihara et al., 2006; Aihara et al., 2010).  The segment on 
TnIf adjacent to Cys133 binds to the hydrophobic pocket in the N-lobe of TnC in the Ca
2+
 bound 
state, and swings back to be frequently near actin in the absence of Ca
2+
.  With S-glutathionylation, 
the glutamate residue of glutathione adds a negative charge at the cysteine residue, and this together 
with the accompanying steric effects is thought to exert an action similar to or even greater than 
occurs with protein phosphorylation (Klatt & Lamas, 2000; Dalle-Donne et al., 2007).  It seems that 
the net effect of this is to bias the movements of the flexible Cys133 region of TnIf more towards 
the TnC bound state, so that the interaction between TnI and TnC that controls contractile activation 
occurs at lower cytoplasmic [Ca
2+
]. 
 
Interestingly, although TnIs does not have a cysteine residue matching Cys133 in TnIf, it does have 
a serine residue in the corresponding position (Ser134), raising the possibility that phosphorylation 
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of TnIs at Ser134 may play a similar role in modifying the Ca
2+
-sensitivity of contraction in type I 
fibres.  Furthermore, cardiac TnI (TnIc) also has a serine residue in the homologous location 
(Ser166 in rat and Ser165 in human), adjacent to region binding in the hydrophobic pocket of 
cardiac TnCc, and phosphorylation of this residue on TnIc
 
impedes binding of TnIc to TnCc (Ward et 
al., 2001).  However, such phosphorylation does not occur when TnIc is in the normal troponin 
complex (Ward et al., 2001).  In view of the major effects on Ca
2+
-sensitivity found here with 
S-glutathionylation of Cys133 in TnIf, the intriguing structural parallels with TnIs and TnIc suggest 
that a detailed investigation of the occurrence and possible functional changes occurring with 
phosphorylation at these sites may be warranted.  
 
Functional relevance of S-glutathionylation of TnIf 
S-glutathionylation of TnIf was produced in the present study primarily by unphysiological means, 
in particular by applying DTDP-GSH or a very high level of GSSG that would never be reached in 
a muscle cell.  However, the same basic process could be expected to quite readily occur in muscle 
fibres.  Cys133 of TnIf is evidently a highly reactive and accessible cysteine residue (results here 
and (Chong & Hodges, 1982; Tao et al., 1990; Park et al., 1994)) and hence could be expected to 
readily react with many of the variety of reactive oxygen and nitrogen species, and other related 
reactive species, generated during muscle activity (Reid et al., 1992; Allen et al., 2008; Powers & 
Jackson, 2008; Lamb & Westerblad, 2011), leading by various means to its S-glutathionylation in 
the presence of cytoplasmic GSH (see Introduction).  The rate at which the cytoplasmic GSH 
subsequently reduces the glutathionylated cysteine residue on TnIf back to a free sulphydryl was 
found previously to be relatively slow, with only ~50% reversal occurring in 20 min in the presence 
of 5 mM GSH (Lamb & Posterino, 2003).  This would help favour accumulation of TnIf in the 
S-glutathionylated state.  However, reversal may occur faster in-vivo at higher temperature and with 
the presence of glutaredoxins and thioredoxins (Dalle-Donne et al., 2007). 
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Most importantly, the present study found that moderate intensity cycling exercise for 40 min led to 
a ~4-fold increase in S-glutathionylation of TnIf in the vastus lateralis muscle of human subjects 
(Fig. 11).  Given that S-glutathionylation of TnIf of human type II fibres was found, like in rat type 
II fibres, to result in a large increase in Ca
2+
-sensitivity (Fig.s 8 & 9), it seems reasonable to 
conclude that S-glutathionylation of TnIf is likely to be a significant factor influencing muscle 
performance in exercising humans.  Increasing the Ca
2+
-sensitivity of the contractile apparatus in 
this way could be of great benefit in countering factors occurring with normal exercise which 
decrease contractile sensitivity, such as the build-up of inorganic phosphate which is thought to be a 
major factor in causing muscle fatigue (Allen et al., 2008). 
 
S-glutathionylation of TnIf not only increases contractile Ca
2+
-sensitivity considerably but also 
increases the peak twitch force and rate of force development to action potential stimulation (see 
Fig 4 in (Dutka et al., 2011b)).  Thus, the overall effects of S-glutathionylation of TnIf are highly 
comparable to those occurring with phosphorylation of myosin light chain 2 (Szczesna et al., 2002; 
Stull et al., 2011), with both causing similar size increases in Ca
2+
-sensitivity and similar twitch 
force potentiation in fast-twitch muscle fibres, though by distinctly different mechanisms.  It is 
interesting that the potentiating effects of myosin light chain phosphorylation are seen within a 
matter of seconds from onset of intense muscle stimulation (Stull et al., 2011) and that the extent of 
MLC2 phosphorylation is greatly reduced after more prolonged fatiguing stimulation even though 
twitch potentiation still persists (Tubman et al., 1996).  The latter finding, together with that fact 
that fatiguing stimulation causes twitch potentiation even in myosin light chain kinase knockout 
mice has led to the suggestion that other mechanisms can also seemingly cause such post-activation 
potentiation when muscle has undergone a period of fatiguing stimulation (Tubman et al., 1996; 
Stull et al., 2011).  Clearly, the findings of this study suggest that S-glutathionylation of TnIf would 
fulfill such a role, especially given that its effects would be expected to increase with the duration 
and extent of muscle activity owing to the likely increased total generation of reactive oxygen and 
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related species.  However, if the activity continued for too long it is possible that other deleterious 
effects of the oxidants could antagonize and counter the potentiating effects of the 
S-glutathionylation of TnIf (Andrade et al., 1998; Lamb & Westerblad, 2011). 
 
Concluding remarks                        
This study has shown that S-glutathionylation of TnIf readily occurs in fast-twitch skeletal muscle 
fibres, including in humans during prolonged strenuous cycling exercise.  Such S-glutathionylation 
greatly increases the rate of force development and the Ca
2+
-sensitivity of the contractile apparatus, 
and such effects could be expected to substantially influence muscle performance, in particular 
helping counter the effects of other factors that decrease contractile sensitivity or sarcoplasmic 
reticulum Ca
2+
 release that if unchecked potentially lead to reduced force responses and ‘muscle 
fatigue’.   Additionally, the findings implicate Cys133 on TnIf as the site of the S-glutathionylation, 
and this seemingly fits well with its location in the flexible region of TnIf adjacent to the region 
binding to TnC during Ca
2+
 activation.  The identification of this molecular process could well 
provide new avenues for understanding muscle dysfunction in particular situations and possibly also 
for the development of novel therapeutic strategies for countering such dysfunction.     
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Table 1.  Changes in Ca
2+
 sensitivity with glutathionylation treatments in type II and type I fibres.  
Data are mean ± s.e.m. (or s.d., where n=2) of the change in pCa50 caused by indicated treatment, 
and by subsequent DTT treatment in a subset of those fibres.  Each treatment applied with skinned 
fibre in the reduced state, except for ‘Post-NEM’ cases, where the fibre was pre-treated with 25 µM 
NEM for 2 min.  Treatments (all applied at pCa 9): 100 µM DTDP for 5 min (or 1 min in chicken 
and toad) followed by 5 mM GSH for 2 min; or 10 mM GSSG at pH 7.1 for 10 min; or 10 mM 
GSSG at pH 8.5 for 10 min.  DTT treatment: 10 mM for 10 min in all cases.  Number of fibres 
shown in brackets.  N.D., not determined.  Fibres classified as type I or II by Sr
2+
 activation 
properties, and verified by western blotting.  * denotes significantly different from zero (P<0.05); 
samples with n=2 not statistically compared.   
 
 
 
      Treatment             pCa50 after treatment       pCa50 after DTT   
 
      A             B    
Rat Type II 
 
  1)  DTDP-GSH   +0.238 ± 0.005 (18)
 
*         -0.240 ± 0.004 (11)*   
 
 
  2)  DTDP-GSH (Post-NEM) +0.030 ± 0.007 (8)
 
*          -0.045 ± 0.004 (5)
 
*    
 
  3)  GSSG pH 7.1   +0.055 ± 0.010 (3)
 
*                    N.D. 
  
  4)  GSSG pH 8.5   +0.191 ± 0.009 (7)
 
*         -0.218 ± 0.003 (2)    
                
  5)  GSSG pH 8.5 (Post-NEM) -0.003 ± 0.004 (2)                    N.D. 
          
Rat Type I 
 
  6)  DTDP-GSH   -0.018 ± 0.008 (7)         -0.009 ± 0.003 (6)
 
*     
 
 7 )  GSSG pH 8.5   -0.023 ± 0.010 (2)         -0.015 ± 0.001 (2)       
 
Human Type II 
 
  8)  DTDP-GSH   +0.171 ± 0.009 (3)
 
*          -0.196 ± 0.012 (3)
 
*       
 
 
Toad Type II   
 
  9)  DTDP-GSH   -0.010 ± 0.006 (5)
 
          +0.006 ± 0.008 (4)     
 
Chicken Type II   
 
  10)  DTDP-GSH   -0.051 ± 0.013 (3)
 
          +0.001 ± 0.009 (2)     
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Table 2.  Effect of glutathionylation after substituting fast troponin isoforms into slow-twitch fibres.  Mean ± s.e.m. (or s.d., where n=2) of change in 
pCa50 occurring with the indicated treatment in slow-twitch (i.e. type I) fibres from rat soleus muscle.  n is the number of fibres examined.  Treatments 
applied sequentially in order left to right across table.  Substituted fast troponins were from porcine or rabbit muscle as indicated.    N.A., not 
applicable.  ‘L& P, 2003’ denotes data from Lamb & Posterino (2003), carried out with same conditions as this study.   * significantly different from 
zero (P<0.05).   
 
                   Treatment              
                                                                                      
           Troponin Exch.        DTDP          GSH         DTT          
                   A1           A2            B        
   
1)  Control soleus fibres                  N.A.   -0.059 ± 0.0027 +0.001 ± 0.002 +0.023 ± 0.011  
       (L & P, 2003)  (n=5) 
 
2)  Control soleus fibres                 N.A.   -0.028 ± 0.001  +0.012 ± 0.004 -0.004 ± 0.017   
         This study    (n=2) 
 
3)  Soleus fibres with porcine Troponin      +0.455 ± 0.030
 
*  -0.094 ± 0.016
 
*    +0.126 ± 0.027
 
* -0.134 ± 0.022
 
*   
        This study    (n=3) 
 
4)  Soleus fibres with rabbit Troponin      -0.047 ± 0.001  -0.006 ± 0.028
 
   +0.031 ± 0.006
 
 -0.069 ± 0.043    
        This study    (n=2) 
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Figure 1. (see over) 
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Figure 1.  Treatment with GSSG-pH 8.5 increases Ca
2+
 sensitivity of contractile apparatus.  
A, Isometric force production in a skinned EDL fibre to solutions with successively higher free [Ca
2+
], 
starting at pCa >9 (small ticks in order: pCa 6.40, 6.22, 6.02, 5.88, 5.75, 5.48, 4.7, >9).  Sequence 
repeated twice after each treatment, giving very similar results; only the second of each pair of force-
pCa staircases is shown for each treatment.  Maximum Ca
2+
-activated force reached at pCa 4.7.  
Horizontal arrows mark force level achieved at pCa 5.75.  Treatments (all applied at pCa >9): 10 mM 
DTT for 10 min; pH 8.5 for 10 min; 10 mM GSSG at pH 8.5 for 10 min; 100 µM DTDP for 5 min 
followed by 5 mM GSH for 2 min (i.e. ‘standard DTDP-GSH treatment’).  B, Hill fits to force-pCa data 
following each indicated treatment; data from panel A, with force responses in each ‘staircase’ 
normalised to their own maximum.  C, pCa50 values after indicated treatment for Hill fits in B. 
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Figure 2.   Constancy of net increase in Ca
2+
-sensitivity with sequential GSSG and DTDP-GSH 
treatments.  Increase in pCa50 when individual EDL fibres were first subjected to a submaximal or 
near maximal GSSG treatment (pCa50 shift plotted as abscissa value) and then afterwards subjected to 
the standard DTDP-GSH treatment (additional increase in pCa50 plotted as ordinate value); the total 
overall increase in pCa50 was similar irrespective of the initial GSSG treatment.  The different first 
treatments (all lasting 10 min) were: 10 mM GSSG at pH 7.1 (); 2.5 mM GSSG at pH 8.5 (▼); 5 mM 
GSSG at pH 8.5 (♦); and 10 mM GSSG at pH 8.5 (▲).  The value on the ordinate axis (■) (i.e. +0.238 
pCa units) represents the effect of DTDP-GSH treatment without any first treatment (see Table 1).  In 
all cases subsequent DTT treatment (10 mM, 10 min) fully reversed Ca
2+
-sensitivity to its original level 
(i.e. by ~ -0.24 pCa units in all cases) (not shown). 
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Figure 3.  Pre-treatment with NEM blocks action of DTDP-GSH on Ca
2+
-sensitivity.  A, Hill fits 
for force-pCa data for a rat EDL fibre given the standard DTDP-GSH treatment both before and after 
treatment with NEM (25 µM, 2 min, at pCa >9).  Two successive force-pCa staircases examined after 
each treatment, with very similar results; data only for second in each pair plotted here.  B, pCa50 
values following indicated treatment for data in A.  Note that there is a small progressive decline in 
pCa50 with each force-pCa staircase, which occurs even with no treatment (~0.012 pCa units per 
staircase pair) (here compare ‘CON’ (control) and subsequent post ‘DTT’ responses). 
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Figure 4.  DTDP-GSH treatment causes S-glutathionylation of troponin I fast isoform (TnIf).   
A, Upper panel: Western blot with anti-GSH antibody in EDL fibre samples (5 fibre segments per 
sample) subjected to indicated treatment (all at pCa >9) (15% SDS-PAGE).  In all cases fibres washed 
initially for at least 5 min in pCa > 9. Lane 1, control treatment (Con), 10 min washing at pCa >9; Lane 
2, 5 mM SNAP for 5 min; Lane 3, 100 µM DTDP for 5 min, 5 mM GSH for 2 min (i.e. ‘standard 
DTDP-GSH treatment’); Lane 4, 10 mM DTT for 10 min.  All samples blocked with 5 mM NEM for 
5 min before adding SDS (see Methods).  Arrows indicate bands corresponding to TnI.  The bands at 
~43 kDa correspond to actin.  Lower panel: subsequent reprobe of same membrane for troponin I 
(TnI); EDL fibres contain only the fast isoform, TnIf.  Positions of molecular weight markers shown on 
left (see Methods).  B, Middle panel: anti-GSH blot of EDL fibres given indicated treatments as in 
panel A. (12.5% SDS-PAGE).  Lane 3: Fibres treated with NEM (200 µM, 2 min), followed by DTT 
(10 mM, 10 min), then standard DTDP-GSH treatment. Membrane reprobes for TnI (bottom) and then 
actin (top).  C, mean +SE ratio of band density for anti-GSH signal relative to corresponding TnIf 
signal for indicated treatments, expressed relative to DTDP-GSH case on same gel.  Number of 
independent gels shown in each bar.  * significantly different (P <0.001) from DTDP-GSH case.  
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Figure 5.  Biotin labeling of reactive cysteines.   
Western blot of single skinned EDL fibre segments treated in relaxing solution with a biotin-tagged 
thiopyridine reagent (Biotin HPDP) for either 1 or 5 min, and probed for biotin with strepatividin (see 
Methods).  The one min exposure to the reagent produced clear labeling of the TnI isoform present 
(TnIf), but an even a more prolonged (5 min) exposure produced no detectable labeling of either TnC or 
MLC2 (both run at ~18 kDa).  12.5% SDS-PAGE 
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Figure 6.  Freshly-prepared GSNO produces S-glutathionylation of TnIf.  EDL type II fibres (4 
fibre segments per sample) were subjected to control treatment (‘Con’, 10 min wash only) or to a 2 min 
treatment with GSNO (2 mM) either immediately after it was prepared (‘Imm’) or 10 min after it was 
prepared (delayed, ‘Del’).  Fibres first washed for 5 min before either GSNO treatment.  All solutions 
were at pCa >9.  Middle panel: Western blot with anti-GSH antibody.  Lower panel: Reprobe of 
membrane for TnI.  Top panel: MHC band in commassie-stained gel post-transfer.  15% SDS-PAGE. 
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Figure 7.  Effect of S-glutathionylation following partial TnIf exchange into a type I fibre.  A, 
Ca
2+
-activated force responses in skinned segment of a rat soleus type I fibre following exchange of 
porcine fast-twitch troponin (see Methods).  [Ca
2+
] initially pCa >9 and raised progressively (small 
ticks) in order: pCa 6.70, 6.40, 6.22, 6.02, 5.88, 5.75, 5.48, 4.7, >9).  Fibre treated successively with 
DTDP (100 µM, 5 min), GSH (5 mM, 2 min), and DTT (10 mM, 10 min).  [Ca
2+
] sequence repeated 
twice after each treatment, giving very similar force responses; only second of each pair shown.  
Horizontal arrows indicate force level at pCa 6.40 in each case.  B, Hill fits to force-pCa data in A.  C, 
Western blotting for TnI, TnC and actin in soleus single fibre segments with (Exch) and without (Con) 
troponin exchange.  The segment producing the force responses in A & B was run in Lane 2; virtually 
all of the endogenous TnC, and ~35% of the TnI, was replaced with the respective fast isoform (see 
text).  Lane 4: another fibre following troponin exchange.  Lanes 1 and 3: Untreated control fibres.  
Lane 5: 0.5 pmol of the exogenous porcine troponin complex (Tn).  8-16% Criterion Stainfree gel.
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Figure 8.  Glutathionylation treatment causes increased Ca
2+
-sensitivity in human type II fibres 
but not type I  fibres.  Segments of individual fibres from vastus lateralis muscle biopsy from a rested 
human subject were mounted on the force transducer and force-pCa staircases recorded.  A, Hill curves 
for human type II fibre subjected to standard DTDP-GSH treatment and then DTT treatment.  B, 
Western blots of human single fibres, probed first for TnI, then TnC, MHCII and finally MHCI.  Fibre 
in panel A run in Lane 1.  Force response of fibres to pSr 5.2 in accord with TnC isoform in every case 
(see text).  4-15% Criterion TGX Stainfree gel.  C, Hill curves for human type I fibre subjected to 
successive treatments with DTDP (100 µM, 5 min), GSH (5 mM, 2 min), and finally DTT (10 mM, 
10 min).   
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Figure 9.  TnIf runs more slowly when S-glutathionylated.  A, Western blots of tissue sections from 
rat EDL and human vastus lateralis muscles subjected either to a wash only (lanes 1 and 3, ‘-’) or to 
wash with DTDP (100 µM) and then GSH (5 mM) (lanes 2 and 4, ‘+’).  (Adjacent transverse sections 
of frozen muscles used; treated at room temperature, all in K-HDTA ‘intracellular’ solution at pCa >9).  
Middle panel: Anti-GSH antibody shows DTDP-GSH treatment increased glutathionylation of TnIf in 
rat EDL muscle and of both TnIf and TnIs in human muscle (lower and upper bands respectively).  
Bottom panel: Reprobe with TnI antibody: only fast isoform (TnIf) is present in rat EDL muscle, 
whereas both TnIf and TnIs are present in the human muscle.  Note that TnIf runs at a slightly higher 
molecular weight following treatment with DTDP-GSH in both the rat and human muscle.  8-16% 
Criterion Stainfree gel.  B, Diagrammatic representation of exposed and hidden cysteine residues on the 
troponin complex in mammalian fast-twitch (type II) muscle fibres (modified from Chong & Hodges, 
1982; © 1982 The American Society for Biochemistry and Molecular Biology).  Letters I, C and T 
indicate TnIf, TnCf and TnTf subunits, and numbers indicate cysteine residues on TnIf and TnCf (there 
are none on TnTf).  Only Cys133 on TnIf is readily accessible to cysteine reagents.  TnIs (not shown) 
lacks an equivalent of Cys133, having Cys38, Cys65 and Cys85, with Cys65 being homologous to Cys 
64 on TnIf. 
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Figure 10.  No S-glutathionylation of TnIf in toad fibres.  Western blot with anti-GSH (upper panel) 
and subsequent reprobe for TnI (lower panel).  Rat EDL fibres in lanes 1 & 2 and 5 & 6, and toad 
iliofibularis fibres in lanes 3 & 4 and 7 & 8 (four fibre segments in each sample).  Fibres in left lane of 
each pair (i.e. in lanes 1, 3, 5 and 7) given standard DTDP-GSH treatment (+), and fibres in adjacent 
lanes (2, 4, 6, and 8) washed in same solution without DTDP and GSH (-).  In the rat EDL fibres the 
DTDP-GSH treatment caused a very marked increase in the anti-GSH signal corresponding to TnIf 
(arrow) (compare lanes 1 & 3 with 2 & 6), but no other proteins in the rat fibres showed much increase 
with treatment.  (Note that the anti-GSH signal at ~43 kDa arising from actin is overexposed and 
appears white).  TnIf in the toad fibres displayed no anti-GSH signal, either with or without the 
treatment; note that the anti-GSH signal seen in the toad fibres running similar to the rat TnIf signal 
does not arise from the toad TnIf, which runs at an appreciably lower molecular weight, as seen in the 
TnI reprobe below.  M: molecular markers (see Methods).  4-15% Criterion TGX Stainfree gel. 
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Figure 11.  Increased S-glutathionylation of TnIf in human muscle with prolonged exercise. 
A, western blot with anti-GSH, and subsequent reprobe for TnI, of transverse sections from vastus 
lateralis muscle biopsies taken from two human subjects both before (‘pre’) and after 40 min cycling 
exercise at ~60% of VO2max (‘exerc’).  The anti-GSH signal indicated by arrow overlaid with the TnIf 
bands (lower of the two TnI bands).  Increased glutathionylation was also evident at ~14 kDa in these 
two post-exercise cases.  Top panel shows corresponding MHC bands imaged in stainsfree gel before 
protein transfer.  4-20% Criterion Stainfree gel.  B, Mean data (+sem) from 5 subjects for the TnIf 
S-glutathionylation signal before and after exercise (all samples run on same gel, repeated three times).  
The density of each TnIf glutathionylation signal was first normalised by the corresponding TnIf band 
density, and then each value was re-expressed relative to the mean of the pre-exercise cases on that gel 
(effectively declaring latter as ‘1’); values from 3 repetitions averaged to yield a single value for each 
pre- and post-exercise sample for each subject . * significantly greater than ‘pre’ (paired t-test, n = 5 
subjects, P<0.05, one-sided Wilcoxin signed rank test). 
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